Viewing nowCombinationDapagliflozin/Metformin Extended-Release Tablet 5/1000 mg
Metformin Hydrochloride 1000mg · Dapagliflozin Bis L-proline 7.8mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.

MFDS item code 202202498 · Approved 2022.06.15 · Insurance code 643508570
Improves glycemic control in adults with type 2 diabetes mellitus
This medication is used to improve blood sugar control in adult patients with type 2 diabetes, along with dietary and exercise therapy. It is particularly important to consult additional expert information regarding the safety and efficacy of dapagliflozin in patients with cardiovascular disease or risk factors who are not adequately controlled. This medication effectively aids in blood sugar management and is used in the treatment of type 2 diabetes.
The dose of this medicine should be individualized based on the patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended doses of dapagliflozin 10mg and extended-release metformin 2000mg. This medicine is generally administered once daily with the evening meal. The maximum dose of this medicine is dapagliflozin 10mg/extended-release metformin 2000mg once daily, administered as 2 tablets of 5mg/1000mg. When used as initial therapy in patients with no prior history of antidiabetic drug treatment, the recommended starting dose of this medicine is 1 tablet of 5mg/500mg or 10mg/500mg once daily. Adjust the dose gradually to reduce gastrointestinal adverse reactions associated with metformin. For patients treated with metformin, the recommended dose of dapagliflozin is 10mg once daily; the dose of this medicine should provide the same dose of metformin the patient was taking, or an appropriate dose therapeutically close to it. For patients switching to this medicine from combination therapy with dapagliflozin and metformin, the dose of this medicine may be started at the doses of dapagliflozin and metformin previously administered. When this medicine is used in combination with insulin or an insulin secretagogue such as a sulfonylurea, a lower dose of insulin or the insulin secretagogue may be considered to reduce the risk of hypoglycemia. No dose adjustment is necessary in patients with mild renal impairment. For patients with an estimated glomerular filtration rate (eGFR) of 45 mL/min/1.73 m2 or higher and less than 60 mL/min/1.73 m2, and without other conditions that may increase the risk of lactic acidosis, the starting dose of metformin hydrochloride, an ingredient of this medicine, is 500mg once daily, and the maximum daily dose is 1000mg. Administration of this medicine is not recommended in patients with an eGFR below 45 mL/min/1.73m2. If the estimated glomerular filtration rate (eGFR) falls below 45 mL/min/1.73m2, discontinue this medicine immediately. Renal function should be assessed every 3~6 months. Since metformin is excreted through the kidneys and renal function is more likely to be reduced in elderly patients, this medicine should be used with caution as age increases.
This medication is used for the treatment of diabetes and helps control blood sugar. It should not be administered to patients with impaired renal function, severe infections, dehydration, or cardiovascular diseases at the time of prescription. It is also safer for pregnant or breastfeeding women not to use this medication. This medication can rarely cause serious metabolic complications known as lactic acidosis, so it is important to consult a doctor immediately if symptoms occur. Additionally, when taken with insulin or sulfonylureas, there is a risk of hypoglycemia, so care is needed. This medication may increase the risk of infections such as genital infections or urinary tract infections, so treatment should be sought promptly if symptoms of infection appear. Patients with reduced fluid volume or at risk of hypotension should carefully monitor blood pressure and renal function before and after taking this medication. Alcohol consumption should be avoided while taking this medication, and regular testing is recommended as vitamin B12 levels may decrease. If you are undergoing surgery or radiation tests which may affect renal function, this medication should be temporarily suspended and resumed only after checking renal function. Elderly patients or those with diminished renal function need to adjust dosages and regularly monitor kidney function. In case of overdose, prompt assessment and appropriate treatment by medical personnel are necessary, as this medication can be removed through dialysis. Lastly, this medication must be kept out of the reach of children and stored in its original container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture from entering, and it is best kept at room temperature between 1 to 30 degrees Celsius. This storage method helps maintain the medication's effectiveness.
A pink, oval, biconvex extended-release film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationMetformin Hydrochloride 1000mg · Dapagliflozin Bis L-proline 7.8mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Cheil Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jeil Pharmaceutical Co., Ltd.
CombinationDapagliflozin Bis L-proline 15.63mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.